文献速递肿瘤 PET/CT放射性药物与辐射防护

FDG-PET/CT用于不明原因发热检查:疾病成本分析

FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-12-07

研究回顾性分析澳大利亚某大型三级教学医院2016年6月至2022年9月1257例发热患者,其中57例符合经典不明原因发热(PUO)标准,31例住院患者、15例门诊患者行FDG-PET/CT,11例住院患者未行FDG-PET/CT。结果显示接受FDG-PET/CT的住院患者平均年龄、住院时间和总费用更高,但每患者床日费用中位数无差异;入院7天内早期行FDG-PET/CT者住院时间更短、总费用更低。

要点

  • 57例经典PUO中31例住院、15例门诊行FDG-PET/CT,11例住院患者未行FDG-PET/CT。
  • 接受FDG-PET/CT的住院患者平均年龄、住院时间和总费用更高,每患者床日费用中位数两组无差异。
  • 入院≤7天早期行FDG-PET/CT者较晚行者住院时间更短、总费用更低。

核心结论

  • FDG-PET/CT在PUO患者中显示出高诊断准确性和对患者管理的显著影响。
  • 入院后较早行FDG-PET/CT与更短住院时间和更低总费用相关。

研究设计与样本

  • 回顾性分析澳大利亚某大型三级教学医院2016年6月至2022年9月1257例发热患者,其中57例符合经典PUO标准。
  • 31例住院患者和15例门诊患者行FDG-PET/CT,11例住院患者未行FDG-PET/CT。

主要发现

  • 接受FDG-PET/CT的住院患者平均年龄、住院时间和总费用高于未接受FDG-PET/CT的住院患者。
  • 两组每患者床日费用中位数无差异。
  • 入院≤7天行FDG-PET/CT的住院患者较晚行者住院时间更短、总费用更低。
  • 10例FDG-PET/CT阴性(无严重或危及生命异常)患者中7例(70%)随后出院或转至门诊。
  • 40次扫描中11次(28%)发现需进一步评估的附带异常。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Our study aims to explore the current utilisation of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in the diagnostic pathway of pyrexia of unknown origin (PUO) and associated cost of illness in a large tertiary teaching hospital in Australia. METHOD: 1257 febrile patients between June 2016 and September 2022 were retrospectively reviewed. There were 57 patients who met the inclusion criteria of "classical PUO", of which FDG-PET/CT was performed in 31 inpatients, 15 outpatients and 11 inpatients did not have an FDG-PET/CT scan. The patient demographics, clinical characteristics and inpatient cost were analysed, together with the diagnostic performance of FDG-PET/CT and impact on clinical management. RESULT: The mean age, length of stay and total cost of admission were higher for inpatients who received FDG-PET/CT versus those who did not. The median cost per patient-bed-day did not differ between the two groups. Inpatients who received earlier FDG-PET/CTs (≤ 7 days from admission) had shorter length of stays and lower total cost compared to those who received a later scan. A negative FDG-PET/CT scan, demonstrating no serious or life-threatening abnormalities resulted in subsequent discharge from hospital or outpatient clinic in 7/10 (70%) patients. There were 11/40 (28%) scans where ancillary abnormalities were identified, requiring further evaluation. CONCLUSION: FDG-PET/CT showed high diagnostic accuracy and significant impact on patient management in patients with PUO. FDG-PET/CT performed earlier in admission for PUO was associated with shorter length of stay and lower total cost.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Liu B, Ma R, Shum E, et al. FDG-PET/CT for investigation of pyrexia of unknown origin: a cost of illness analysis. Eur J Nucl Med Mol Imaging. 2023. PMID: 38057651. doi:10.1007/s00259-023-06548-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。